Literature DB >> 27773881

Pathogenic characterization of Erysipelothrix rhusiopathiae Met-203 type SpaA strains from chronic and subacute swine erysipelas in Japan.

Mariko Uchiyama1, Yohko Shimazaki, Yukari Isshiki, Akemi Kojima, Fumiya Hirano, Kinya Yamamoto, Mayumi Kijima, Hidetaka Nagai.   

Abstract

To characterize the Erysipelothrix rhusiopathiae Met-203 type surface protective antigen (Spa) A strains causing swine erysipelas in Japan, the nucleotide sequence of the hypervariable region of the spaA gene was determined in 80 E. rhusiopathiae (serotype 1a) isolates collected from pigs with chronic and subacute swine erysipelas in 14 prefectures in 2008-2014. In this study, 14 (17.5%) isolates were Met-203 type SpaA strains. We confirmed the pathogenicity of a Met-203 type SpaA strain in specific-pathogen-free pigs. In this experiment, the two challenged pigs displayed arthritis, urticaria and other clinical signs, but recovered within 10 days. Our results reveal the existence of the E. rhusiopathiae Met-203 type strains that have been causing chronic erysipelas in Japan.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27773881      PMCID: PMC5289231          DOI: 10.1292/jvms.16-0164

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


Erysipelothrix rhusiopathiae is a Gram-positive bacillus and causative agent of swine erysipelas (SE). The clinical signs of SE can be divided into three types: acute (septicemia), subacute (urticaria) and chronic (arthritis, lymphadenitis and endocarditis) [20]. Surface protective antigen (Spa) A is well known as one of the major protective antigens of E. rhusiopathiae [7, 21]. The N-terminal half of the hypervariable region of SpaA in particular has been shown to be important for specific immunity to the infection [3, 13, 17]. On the other hand, Harada et al. [2] demonstrated that SpaA was responsible for the adhesion of E. rhusiopathiae to porcine endothelial cells. Borrathbay et al. [1] also showed that SpaA plays a role in the pathogenesis of E. rhusiopathiae infection by demonstrating that the 50% lethal dose (LD50) of the ΔspaA mutant was lower than that of the parental strain in mice, when the virulence of ΔspaA E. rhusiopathiae strain was examined. Recently, septicemic erysipelas infection caused by a Met-203 type strain of E. rhusiopathiae, in which the amino acid at position 203 of the hypervariable region of SpaA is methionine, was reported by Kanda et al. [5]. To et al. [18] showed that most of the E. rhusiopathiae isolates from the 2008–2011 outbreaks were serotype 1a of the Met-203 type strain and suggested that these types of isolates might be widespread in Japan. We also reported that E. rhusiopathiae Met-203 type strains with serotype 1a of septicemic form were isolated on farms in Japan from 2008 to 2010 [19]. Although many E. rhusiopathiae Met-203 type strains from acute SE cases have been reported, a recent study reported on the isolation of some E. rhusiopathiae Met-203 type strains from subacute or chronic SE cases and their acriflavine resistance patterns and pathogenicity profiles in mice [18]. Meanwhile, Zou et al. [22] reported that a methionine at amino acid position 203 of the hypervariable region of the spaA gene is not directly related to the virulence of E. rhusiopathiae. According to the Slaughterhouse Act of Japan (Act No. 114 of August 1, 1953), a carcass with a lesion from E. rhusiopathiae infection must be condemned. Therefore, the economic losses caused by chronic SE are of great importance to the pig industry. According to Japanese national statistics, the number of condemned pigs with SE in Japanese slaughterhouses has increased since 2009, with sharp increases in 2012 and 2013 [8, 9]. With the aim of contributing information about the recent situation concerning chronic SE and the characteristics of E. rhusiopathiae Met-203 type strains, we determined the nucleotide sequence of the hypervariable region of the spaA gene of E. rhusiopathiae (serotype 1a) isolated from chronic and subacute SE, and investigated their pathogenicities in mice and pigs. A total of 80 E. rhusiopathiae isolates were used in this study (Table 1). They were isolated from pigs with chronic or subacute erysipelas from 14 Japanese prefectures (Iwate, Miyagi, Akita, Fukushima, Ibaraki, Gunma, Saitama, Chiba, Kanagawa, Niigata, Fukui, Mie, Kyoto and Kumamoto) from 2008 to 2014 and were collected from Livestock Hygiene Service Centers and official meat hygiene inspections. From them, sixty isolates originated from arthritis cases, 17 from endocarditis cases and 3 from urticaria cases. E. rhusiopathiae Marienfelde strain (serotype 1a) was used for the growth agglutination (GA) tests.
Table 1.

Origin and classification by year of 80 E. rhusiopathiae strains (serotype 1a) isolated in 14 prefectures

OriginNo. of isolates classified by year
Total
2008200920102011201220132014
Urticaria1113
Endocarditis317617
Arthritis7111011106560
Total111310111812580
E. rhusiopathiae was grown in tryptose phosphate broth and agar (Difco Laboratories, Detroit, MI, U.S.A.) supplemented with 0.1% Tween 80 (pH 7.6). To isolate E. rhusiopathiae from the experimentally infected animals, the selective medium or agar was supplemented with kanamycin (500 µg/ml) and gentamicin (25 µg/ml) [16]. A 432-bp fragment of the N-terminal half of the spaA gene was PCR amplified and sequenced directly, using previously described methods [19]. The DNA data were analyzed with Genetyx Network ver. 9.0.4 (Genetyx Corp., Tokyo, Japan). Based on the sequence analysis, 80 field isolates were classified into four types (Table 2). Fifty-six of the isolates (70%) had isoleucine at amino acid position 203 (Ile-203), which were the predominant type and constantly observed in 2008–2014. This sequence was reported in the E. rhusiopathiae strains of various serotype, such as 1a, 2 (GeneBank accession number AB259654), 8 (AB259656) and 17 (AB259660) [17] and also in the E. rhusiopathiae Koganei 65–0.15 live vaccine strain (AB024082) [4]. We confirmed that 52 of 56 Ile-203 strains were amplified by SNP-based PCR assay for detection of the E. rhusiopathiae live vaccine strain [14], which included just slight amplification. Fourteen isolates (17.5%) were Met-203-type strains, which were observed in 2010, 2012 and 2013, and were often isolated next to the Ile-203 type in these years. Three isolates (3.7%) had methionine and aspartic acid at amino acid positions 203 and 242, respectively (Met-203/Asp-242), which were also seen around the same period (2011–2012). In contrast, the Ala-195 type strain was only seen in 2008–2009.
Table 2.

SpaA types and the number of isolates collected by year

Strain or SpaA type a) Difference of nucleotide b) (amino acid position b,c))
No. of isolates by year
Total (%)
584 (195)609 (203)726 (242)2008200920102011201220132014
Ile-203GAT(Asp)ATT(Ile)GAG(Glu)51289107556 (70.0)
Ala-195GCT(Ala)ATT(Ile)GAG(Glu)617 (8.8)
Met-203GAT(Asp)ATG(Met)GAG(Glu)27514 (17.5)
Met-203/Asp-242GAT(Asp)ATG(Met)GAT(Asp)213 (3.7)

a) SpaA types were determined according to sequence of the 432-bp hypervariable region of the spaA gene. b) Underlined letters: nucleotides that differ from Ile-203 type strain at the same position in the protein sequence. Underlined amino acid abbreviations: amino acids that differ from Ile-203 type strain at the same position in the protein sequence. c) Asp:Aspartic Acid, Ala:Alanine, Ile:Isoleucine, Met:Methionine, Glu:Glutamic Acid.

a) SpaA types were determined according to sequence of the 432-bp hypervariable region of the spaA gene. b) Underlined letters: nucleotides that differ from Ile-203 type strain at the same position in the protein sequence. Underlined amino acid abbreviations: amino acids that differ from Ile-203 type strain at the same position in the protein sequence. c) Asp:Aspartic Acid, Ala:Alanine, Ile:Isoleucine, Met:Methionine, Glu:Glutamic Acid. The pathogenicity tests in mice and pigs were performed using the modified methods of Takahashi et al. [15]. All the animal experiments were conducted in accordance with the National Veterinary Assay Laboratory Guide for the Care and Use of Laboratory Animals and the Animal Welfare Acts of Japan. We used 4-week-old female ddY mice (Nippon SLC, Hamamatsu, Japan) and 3-month-old specific-pathogen-free (SPF) pigs (Zen-Noh Live Stock Co., Ltd., Tokyo, Japan). The LD50 value in mice of each of 10 E. rhusiopathiae isolates (6 from endocarditis cases and 4 from arthritis cases) was determined using the method of Kärber [6]. In mice, the LD50 values (log CFU/mouse) of seven Met-203 type strains (endocarditis origin: 5 and arthritis origin: 2) were 0.30–1.33, while those of the three Met-203/Asp-242 type strains (endocarditis origin: 1and arthritis origin: 2) were 0.81–1.24. We selected the Met-203 type strain (Met-203/Fukui) from arthritis SE as the challenge strain for pigs, because it had the lowest LD50 value in mice. Two pigs were challenged intradermally in the flank with 0.1 ml of the challenge strain (7.1 × 107 CFU/pig). Another pig was kept with the challenged pigs in the same pen as a control. Clinical signs in the pigs were observed for 14 days after challenge. Feces from the rectum were collected from day 1 to day 10 after challenge. Serum samples were collected at the point of challenge and at autopsy (14 days after challenge). To determine the anti-erysipelas antibody titers, a GA test with the E. rhusiopathiae Marienfelde strain was performed as described previously [12]. The results of a challenge study in pigs are shown in Table 3. After challenge with the Met-203/Fukui strain (LD50: 0.77 logCFU/mouse), the two challenged pigs showed the following clinical signs: depression, anorexia, dysstasia, pyrexia (42.1°C and 41.7°C), lameness from arthritis and systemic urticarial lesions. The urticarial lesions were observed as purplish red regions (maximum size of erythema: 3.5 cm ×3.0 cm and 4.0 cm ×3.5 cm) of anthema at injection site and appeared on the 2nd day after challenge. The urticarial lesions in the pigs were observable for about a week and then gradually disappeared. Lameness from arthritis was observed on the 7th day after challenge, followed by recovery. The clinical signs in the two pigs had disappeared completely 10 days after challenge. The control pig showed no clinical signs of infection. The two challenged pigs discharged the bacterium in their feces on days 2–4 post-challenge; the bacterium was the same serotype and had the same spaA gene fragment as that of the challenge strain.
Table 3.

Clinical responses and bacterial shedding from pigs after challenge with the E. rhusiopathiae Met-203/Fukui strain

GroupPig No.Clinical responses a)
Growth agglutinating antibody titer
Bacterial shedding in the fecesb)Re-isolation of challenge strain from organsc)
Pyrexia (°C)ErythemaArthritisBefore challenge14 days after challenge
ChallengeP-1242.1systemic+<4256+iliac lymphonodi, tonsils, synovial fluid
P-1341.7systemic+<4128+iliac lymphonodi, tonsils, synovial fluid

ControlP-1439.5--<4<4--

a) Challenge strain (7.1 × 107 CFU/pig) was not lethal to pigs, and all the clinical responses to it disappeared within 10 days. -; no response. b) +: The challenge strain was recovered from feces on days 2 to 4 after challenge exposure. c) Organs tested:liver, spleen, kidney, heart, lung, iliac lymphonodi, tonsils and synovial fluid.

a) Challenge strain (7.1 × 107 CFU/pig) was not lethal to pigs, and all the clinical responses to it disappeared within 10 days. -; no response. b) +: The challenge strain was recovered from feces on days 2 to 4 after challenge exposure. c) Organs tested:liver, spleen, kidney, heart, lung, iliac lymphonodi, tonsils and synovial fluid. The serum samples collected before the challenge from the three pigs had a GA antibody titer of less than 4. At day 14 post-challenge, the GA antibody titers of the two challenged pigs were 256–128 each, but that of the control pig remained less than 4 (Table 3). Fourteen days after challenge, all three pigs were euthanized and autopsied. Samples for bacterial isolation were collected from the main organs (liver, spleen, kidney, heart, lung and iliac lymphonodi) and from the tonsils and synovial fluid. Isolation and serotyping of the bacteria from each sample were performed by the method of Takahashi et al. [16], and the sequence of the spaA gene fragment of the isolated bacteria was confirmed. At autopsy, the two challenged pigs showed no lesions, but a small increase in slightly cloudy serosanguineous synovial fluid was noted. The control pig showed no signs of disease. The serotype and spaA sequences of 432-bp hypervariable region of the strains isolated from the iliac lymphonodi, tonsils and synovial fluid of the two challenged pigs were the same as those of the challenge strain. E. rhusiopathiae was not isolated from the main organs of the control pig (Table 3). In this study, we investigated E. rhusiopathiae Met-203 strains in the context of chronic or subacute SE, because it often causes whole carcasses to be condemned in slaughterhouses. We showed that 14 of 80 isolates (17.5%) were Met-203 type strains, and 3 isolates (3.7%) were Met-203/Asp-242 type strains. Both the Met-203 type and Met-203/Asp-242 type strains were observed in 2010–2013, and these were often isolated next to Ile-203 type strains in these years. Because the acute form of the Met-203 type strain became prevalent after 2008 [5], we surmise that infections caused by the chronic form of this strain may have occurred after numerous outbreaks of the acute form on farms. This could be one of the factors responsible for the recent increase in the number of condemned pigs in slaughterhouses. In addition, we think that the Ile-203 type strains amplified by SNP-based PCR [14] need further investigation about their association with the E. rhusiopathiae Koganei 65–0.15 live vaccine strain. When Nagai et al. [10] reported the sequence of the 432-bp hypervariable region of the spaA gene as one of the new strain-typing methods for discrimination of the live vaccine strain, E. rhusiopathiae Met-203 type strains were not isolated among the 16 E. rhusiopathiae strains (serotype 1a: 10 and serotype 1b: 6) isolated in 2001–2002 from arthritis cases in the Chubu area of central Japan. However, To et al. characterized 83 E. rhusiopathiae strains from eight Japanese prefectures in 2008–2011 and showed that E. rhusiopathiae Met-203 type strains were isolated from acute, subacute and chronic forms [18]. Our sequence analysis is chronologically consistent with these previous reports [10, 18]. The LD50 values (0.30–1.33) of the Met-203 type strains and Met-203/Asp-242 type strains from chronic SE origin reflect their very high virulence in mice. These LD50 values are comparable with those of our previous report of Met-203 type strains from acute SE cases [19]. Our findings also support the results of other studies in that the majority of strains that caused chronic infections were highly virulent in mice [4, 10, 11]. We examined the pathogenicity of the Met-203/Fukui strain in SPF pigs with negative GA titers and examined whether the bacteria were shed and transmitted by contact. In the challenged pigs, two had arthritis, urticaria and other clinical signs, but recovered within 10 days. The pathogenicity of the Met-203/Fukui strain was obviously lower than that of the Met-203 type strain of septicemia origin reported in our previous study, which was lethal in pigs [19]. However, after recovery, the challenged strain was isolated from the iliac lymphonodi, tonsils and synovial fluid of the challenged pigs; therefore, these pigs were potential carriers of this pathogen. Some temporary bacterial shedding was also observed in the feces of both challenged pigs, but the control pig showed no clinical signs and its GA antibody titer remained less than 4. In our clean experimental environment, contact infection was not observed; however, on farms, E. rhusiopathiae is probably spread by oral infection from contact with infected feces. E. rhusiopathiae Met-203 type strains are considered to be highly pathogenic and cause acute SE characterized by sudden death in pigs [5, 19]. On the other hand, E. rhusiopathiae Met-203 type strains have been isolated from chronic SE. The factor of chronic SE depends not only on the virulence of the E. rhusiopathiae strain but also on the immune status of the pig. And, the variations in the pathogenicity of the Met-203 type strains are still unclear. We have shown that one of the E. rhusiopathiae Met-203 type strains caused arthritis SE and that chronic SE causing E. rhusiopathiae Met-203 type strains exist to a certain extent in Japan. Therefore, it is important to continue monitoring E. rhusiopathiae field isolates and to confirm the prevalence and pathogenicity of the field strains by sequencing the hypervariable region of the spaA gene and with pathogenicity tests.
  17 in total

1.  Truncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigs.

Authors:  Y Imada; N Goji; H Ishikawa; M Kishima; T Sekizaki
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Protective activity of the purified protein antigen of Erysipelothrix rhusiopathiae in pigs.

Authors:  Y Yamazaki; H Sato; H Sakakura; K Shigeto; K Nakano; H Saito; N Maehara
Journal:  Zentralbl Veterinarmed B       Date:  1999-02

3.  Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunity.

Authors:  Y Shimoji; Y Mori; V A Fischetti
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Genetic and antigenic diversity of the surface protective antigen proteins of Erysipelothrix rhusiopathiae.

Authors:  Ho To; Shinya Nagai
Journal:  Clin Vaccine Immunol       Date:  2007-05-02

5.  Serotyping of 800 strains of Erysipelothrix isolated from pigs affected with erysipelas and discrimination of attenuated live vaccine strain by genotyping.

Authors:  Yumiko Imada; Ai Takase; Reiko Kikuma; Yoshifumi Iwamaru; Shigehiro Akachi; Yûji Hayakawa
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Response of growth agglutinating antibody and protection of pigs inoculated with swine erysipelas live vaccine.

Authors:  T Sawada; M Muramatsu; K Seto
Journal:  Nihon Juigaku Zasshi       Date:  1979-12

7.  Differentiation of Erysipelothrix rhusiopathiae strains by nucleotide sequence analysis of a hypervariable region in the spaA gene: discrimination of a live vaccine strain from field isolates.

Authors:  Shinya Nagai; Ho To; Akira Kanda
Journal:  J Vet Diagn Invest       Date:  2008-05       Impact factor: 1.279

8.  Role of surface protective antigen A in the pathogenesis of Erysipelothrix rhusiopathiae strain C43065.

Authors:  Entomack Borrathybay; Feng-Juan Gong; Lei Zhang; Wulumuhan Nazierbieke
Journal:  J Microbiol Biotechnol       Date:  2015-02       Impact factor: 2.351

9.  Serotype, antimicrobial susceptibility, and pathogenicity of Erysipelothrix rhusiopathiae isolates from tonsils of apparently healthy slaughter pigs.

Authors:  T Takahashi; T Sawada; M Muramatsu; Y Tamura; T Fujisawa; Y Benno; T Mitsuoka
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

10.  Characterization of Erysipelothrix rhusiopathiae strains isolated from acute swine erysipelas outbreaks in Eastern China.

Authors:  Yao Zou; Xiaoming Zhu; Hassan Mushtaq Muhammad; Ping Jiang; Yufeng Li
Journal:  J Vet Med Sci       Date:  2015-02-03       Impact factor: 1.267

View more
  5 in total

1.  Serovars and SpaA Types of Erysipelothrix rhusiopathiae Isolated from Pigs in Japan from 2012 to 2019.

Authors:  Misako Morimoto; Atsushi Kato; Hiroe Kojima; Yuta Akaike; Kotoe Nogami; Chihiro Sasakawa; Shinya Nagai; Ho To
Journal:  Curr Microbiol       Date:  2020-11-03       Impact factor: 2.188

2.  Multiplex PCR assay for the simultaneous detection and differentiation of clonal lineages of Erysipelothrix rhusiopathiae serovar 1a strains currently circulating in Japan.

Authors:  Kazumasa Shiraiwa; Yohsuke Ogawa; Sayaka Nishikawa; Masahiro Eguchi; Yoshihiro Shimoji
Journal:  J Vet Med Sci       Date:  2017-06-22       Impact factor: 1.267

3.  Rapid and simple detection of Glaesserella parasuis in synovial fluid by recombinase polymerase amplification and lateral flow strip.

Authors:  Ting-Ting Zhang; Meng-Zhi Liu; Rong-Huan Yin; Long-Quan Yao; Bao-Shan Liu; Ze-Liang Chen
Journal:  BMC Vet Res       Date:  2019-08-14       Impact factor: 2.741

4.  The Swine Erysipelas Vaccine SER-ME Effectively Protects Pigs against Challenge with the Erysipelothrix rhusiopathiae M203/I257 SpaA-Type Variant.

Authors:  Misako Morimoto; Atsushi Kato; Kotoe Nogami; Yuta Akaike; Takaaki Furusawa; Hiroe Kojima; Chihiro Sasakawa
Journal:  Vet Sci       Date:  2022-07-26

5.  Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection.

Authors:  Taya L Forde; Nichith Kollanandi Ratheesh; William T Harvey; Jill R Thomson; Susanna Williamson; Roman Biek; Tanja Opriessnig
Journal:  Front Microbiol       Date:  2020-03-13       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.